Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)

Peer Review reports

Original Submission
30 Sep 2020	Submitted	Original manuscript
3 Nov 2020	Reviewed	Reviewer Report - Ali I Shamseddine
6 Nov 2020	Reviewed	Reviewer Report
7 Dec 2020	Author responded	Author comments - Keisuke Miwa
Resubmission - Version 2
7 Dec 2020	Submitted	Manuscript version 2
8 Dec 2020	Reviewed	Reviewer Report
20 Dec 2020	Reviewed	Reviewer Report - Ali I Shamseddine
21 Dec 2020	Author responded	Author comments - Keisuke Miwa
Resubmission - Version 3
21 Dec 2020	Submitted	Manuscript version 3
Publishing
23 Dec 2020	Editorially accepted
5 Jan 2021	Article published	10.1186/s12885-020-07766-5

Back to article page